Characterization of drug‐related problems and evaluation of pharmacist interventions in the cardiovascular intensive care settings in Thailand

Data regarding drug‐related problems (DRPs) and pharmacist's role in the cardiovascular intensive care units (CICU) from low‐ to middle‐income countries (LMIC) are limited.

[1]  B. Karahalil,et al.  Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital , 2022, BMC Health Services Research.

[2]  G. Udeani,et al.  Role of Clinical Pharmacists in Intensive Care Units , 2021, Cureus.

[3]  J. Roberts,et al.  Standard of ​practice in intensive care for pharmacy services , 2021 .

[4]  M. Salehi,et al.  Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017 , 2021, BMC Public Health.

[5]  D. Mark,et al.  Disparities in Cardiovascular Research Output and Disease Outcomes among High-, Middle- and Low-Income Countries – An Analysis of Global Cardiovascular Publications over the Last Decade (2008–2017) , 2021, Global heart.

[6]  Eun Sug Park,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[7]  J. Jacobi,et al.  Position Paper on Critical Care Pharmacy Services (Executive Summary): 2020 Update. , 2020, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[8]  J. P. Engle,et al.  U.S.-Thai Consortium for the development of pharmacy education in Thailand: History, progress, and impact , 2020 .

[9]  Tao Huang,et al.  Drug-Related Problems Identified During Pharmacy Intervention and Consultation: Implementation of an Intensive Care Unit Pharmaceutical Care Model , 2020, Frontiers in Pharmacology.

[10]  D. Prabhakaran,et al.  Prevention and management of CVD in LMICs: why do ethnicity, culture, and context matter? , 2020, BMC Medicine.

[11]  N. Safaie,et al.  The Impact of Clinical Pharmacist Interventions on Medication Errors Management in the Postoperative Cardiac Intensive Care Unit , 2020, Pharmaceutical Sciences.

[12]  L. Ytrebø,et al.  Effects of implementing a clinical pharmacist service in a mixed Norwegian ICU , 2015, European journal of hospital pharmacy. Science and practice.

[13]  M. Walsh,et al.  The role of the clinical pharmacist in the care of patients with cardiovascular disease. , 2015, Journal of the American College of Cardiology.

[14]  Jinwoo Lee,et al.  Pharmacotherapeutic Problems and Pharmacist Interventions in a Medical Intensive Care Unit , 2015 .

[15]  J. Friedrich,et al.  Do we need a pharmacist in the ICU? , 2015, Intensive Care Medicine.

[16]  S. Mojal,et al.  Patient risk factors for developing a drug-related problem in a cardiology ward , 2014, Therapeutics and clinical risk management.

[17]  S. Mojal,et al.  Design of a score to identify hospitalized patients at risk of drug‐related problems , 2014, Pharmacoepidemiology and drug safety.

[18]  C. Shastry,et al.  Assessment of Drug Related Problems in Patients with Cardiovascular Diseases in a Tertiary Care Teaching Hospital , 2014 .

[19]  K. Alexander,et al.  Medication Errors in Acute Cardiovascular and Stroke Patients: A Scientific Statement From the American Heart Association , 2010, Circulation.

[20]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[21]  D Teres,et al.  Critical care delivery in the intensive care unit: Defining clinical roles and the best practice model , 2001, Critical care medicine.

[22]  M. Rudis,et al.  Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services. , 2000, Critical care medicine.